Inhibition of hepatic metastasis in mice treated with cell-binding domain of human fibronectin and angiogenesis inhibitor TNP-470

No abstract is available for this paper.

• Publication year

  2001

• Venue

  International Journal of Clinical Oncology

• Publication date

  2001-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/PL00012108PMID 11723742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of Experimental Metastasis of Human Fibrosarcoma Cells by Anti‐recombinant 37‐kDa Laminin Binding Protein Antibody

  1999cited by this paper
• Inhibition of Liver Metastasis of Human Pancreatic Carcinoma by Angiogenesis Inhibitor TNP‐470 in Combination with Cisplatin

  1998cited by this paper
• Suppressive Effect of the Angiogenesis Inhibitor TNP‐470 on the Development of Carcinogen‐induced Hepatic Nodules in Rats

  1998cited by this paper
• Regression of Metastatic Liver Tumors in Rats Treated with Angiogenesis Inhibitor TNP‐470: Occurrence of Apoptosis and Necrosis

  1997cited by this paper
• Prevention of Liver Metastasis by Cell-binding Domain.

  1996cited by this paper
• In vitro and in vivo stimulation of the murine immune system by AGM-1470, a potent angiogenesis inhibitor.

  1996cited by this paper
• Inhibition of Liver Metastasis of Human Gastric Carcinoma by Angiogenesis Inhibitor TNP‐470

  1996cited by this paper
• The angiogenesis inhibitor TNP-470 (AGM-1470) improves long-term survival of rats with liver metastasis.

  1996cited by this paper
• Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP‐470, and mitomycin c on the growth and liver metastasis of human colon cancer

  1995cited by this paper
• Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470.

  1995cited by this paper
• Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

  1995cited by this paper
• Intra-arterial administration of the angiogenesis inhibitor TNP-470 blocks liver metastasis in a rabbit model.

  1995cited by this paper
• Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg (YIGSR)-containing polypeptide from laminin.

  1994cited by this paper
• Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).

  1994cited by this paper
• Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.

  1994cited by this paper
• AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle.

  1994cited by this paper
• Laminin receptors and laminin-binding proteins during tumor invasion and metastasis.

  1993cited by this paper
• Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).

  1993cited by this paper
• Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.

  1991cited by this paper
• Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

  1990cited by this paper
• Biochemical interactions of tumor cells with the basement membrane.

  1986cited by this paper
• Human tissue fibronectin: expression of different isotypes in the adult and fetal tissues.

  1986cited by this paper
• Domain structure of the carboxyl-terminal half of human plasma fibronectin.

  1983cited by this paper
• Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors

  1972cited by this paper

• New mouse model based on adenocarcinoma 4T1 cells expressing HPV16 E6 and E7 applied to assess the efficacy of therapeutic and prophylactic E6/E7-based HPV16 vaccines

  2025cites this paper
• New mouse model based on adenocarcinoma 4T1 cells expressing HPV16 E6 and E7 applied to assess the efficacy of therapeutic and prophylactic E6/E7-based HPV16 vaccines

  2025cites this paper
• Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver

  2015cites this paper
• In vitro assessment of the cytotoxic effects of novel RGD analogues

  2012cites this paper
• Clinical significance of fibronectin expression in colorectal cancer.

  2008cites this paper
• Recombinant CBD-HepII polypeptide of fibronectin inhibits alphavbeta3 signaling and hematogenous metastasis of tumor.

  2008cites this paper
• Recombinant CBD–HepII polypeptide of fibronectin inhibits αvβ3 signaling and hematogenous metastasis of tumor

  2008cites this paper
• Combination therapy with cell-binding domain, angiogenesis inhibitor and Ca 2+ channel blocker in mice metastatic model

  2008cites this paper
• TNP-470: The Resurrection of the First Synthetic Angiogenesis Inhibitor

  2008cites this paper
• Gene profile analysis of colorectal cancer cell lines by cDNA macroarray.

  2007cites this paper
• Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD‐HepII polypeptide of fibronectin

  2007cites this paper
• In vitro and in vivo analyses of the biological activity of RGD peptides towards Ab Bomirski melanoma.

  2003cites this paper
• Efficacy of intra-tumor injection of Xiao-Zhi-Ling on transplanted hepatoma in rats.

  2003cites this paper
• Experimental study on therapeutic effect of in vivo expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma.

  2003cites this paper
• Effect of Gelatins on Human Cancer Cells In Vitro

  2003influential citation